Messages in brief
Questions and answers about counterfeit drugs Herceptin, Alimta and Remicade
Safety warnings
|
messages in brief
|
25/04/2014
Questions and answers about the stolen vials of Herceptin and other affected products
Questions and answers about counterfeit drugs Herceptin, Alimta and Remicade
Read more
New information on Herceptin theft
Safety warnings
|
messages in brief
|
17/04/2014
Situation Austria: currently only parallel marketed Italian Herceptin and Alimta are affected (as of 18.4.2014).
The drug Herceptin is approved…
Deactivation of the e-mail address "spc-vete@ages.at" for veterinary medicines
messages in brief
|
17/04/2014
Austrian "Summaries of Product Characteristics", "Labellings" and "Patient Information Leaflets" should now be submitted via PHAROS eService…
Deactivation of the e-mail address "spc-vete@ages.at" for veterinary medicines
Read more
Counterfeit Herceptin (trastuzumab)
Safety warnings
|
messages in brief
|
16/04/2014
European Medicines Agency warns against counterfeit Herceptin
Counterfeit Herceptin (trastuzumab)
Read more
Protelos/Osseor
Safety warnings
|
messages in brief
|
21/02/2014
European Medicines Agency recommends restriction of use of Protelos/Osseor
Protelos/Osseor
Read more
Important information about differences in thromboembolism risk of combined oral contraceptives.
Safety warnings
|
messages in brief
|
03/02/2014
Prescription of CHCs and importance of individual risk factors.
Important information about differences in thromboembolism risk of combined oral contraceptives.
Read more
Re-evaluation of the effectiveness of emergency contraception "morning-after pill" started
Safety warnings
|
messages in brief
|
24/01/2014
Re-evaluation with regard to higher body weight or BMI
Re-evaluation of the effectiveness of emergency contraception "morning-after pill" started
Read more
Incorrect use of Eldisin 5 mg dry vial (Vindesin Sulfate).
Safety warnings
|
messages in brief
|
20/12/2013
The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a…
BASG statement
messages in brief
|
07/10/2013
Policy 0070 on publication and access to clinical-trial data
BASG statement
Read more
Federal Office for Safety in Health Care
messages in brief
|
07/10/2013
New management of AGES Medical Market Surveillance
Federal Office for Safety in Health Care
Read more
